Zimmer Biomet Holdings: Q4 Earnings Insights
Zimmer Biomet Holdings (NYSE:ZBH) reported its Q4 earnings results on Monday, February 7, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Zimmer Biomet Holdings Q4 EPS $1.95 Misses $1.98 Estimate, Sales $2.04B Miss $2.07B Estimate
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $1.95 per share which missed the analyst consensus estimate of $1.98 by 1.52 percent. This is a 7.58 percent decrease over earnings of $2.11 per share from
5 Stocks To Watch For February 7, 2022
Some of the stocks that may grab inve3stor focus today are:
Wall Street expects Tyson Foods, Inc. (NYSE: TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the closing bell. Tyson Foods shares rose 1.1% to $89.25 in pre-market trading.
Zimmer Biomet Holdings’s Earnings: A Preview
Zimmer Biomet Holdings (NYSE:ZBH) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement.
Analysts estimate that Zimmer Biomet Holdings will likely report an Earnings Per Share (EPS) of $1.98.
10 Biggest Price Target Changes For Wednesday
Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.
UBS Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $130
UBS analyst Matthew Taylor downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Buy to Neutral and lowers the price target from $172 to $130.
Needham Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $155
Needham analyst Mike Matson maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $158 to $155.